AU678561B2 - Pharmaceutical compositions and methods for treating cold symptoms - Google Patents

Pharmaceutical compositions and methods for treating cold symptoms Download PDF

Info

Publication number
AU678561B2
AU678561B2 AU49307/93A AU4930793A AU678561B2 AU 678561 B2 AU678561 B2 AU 678561B2 AU 49307/93 A AU49307/93 A AU 49307/93A AU 4930793 A AU4930793 A AU 4930793A AU 678561 B2 AU678561 B2 AU 678561B2
Authority
AU
Australia
Prior art keywords
cold
composition according
pharmaceutical
pharmaceutical composition
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU49307/93A
Other languages
English (en)
Other versions
AU4930793A (en
Inventor
Carmelita Macklin Russell
James Grigg Upson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of AU4930793A publication Critical patent/AU4930793A/en
Application granted granted Critical
Publication of AU678561B2 publication Critical patent/AU678561B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
AU49307/93A 1992-10-09 1993-09-22 Pharmaceutical compositions and methods for treating cold symptoms Ceased AU678561B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95501392A 1992-10-09 1992-10-09
US955013 1992-10-09
PCT/US1993/008887 WO1994008551A2 (en) 1992-10-09 1993-09-22 Pharmaceutical compositions and methods for treating cold symptoms

Publications (2)

Publication Number Publication Date
AU4930793A AU4930793A (en) 1994-05-09
AU678561B2 true AU678561B2 (en) 1997-06-05

Family

ID=25496254

Family Applications (1)

Application Number Title Priority Date Filing Date
AU49307/93A Ceased AU678561B2 (en) 1992-10-09 1993-09-22 Pharmaceutical compositions and methods for treating cold symptoms

Country Status (7)

Country Link
EP (1) EP0662840A1 (es)
JP (1) JPH08502288A (es)
AU (1) AU678561B2 (es)
CA (1) CA2146637C (es)
MX (1) MX9306295A (es)
NZ (1) NZ256346A (es)
WO (1) WO1994008551A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0696190B1 (en) * 1993-04-30 1998-07-15 The Procter & Gamble Company Nasal aromatic releasing compositions
WO1995025518A1 (en) * 1994-03-18 1995-09-28 Ciba-Geigy Ag Aqueous solution of levocabastine for ophthalmic use
US5698181A (en) * 1994-12-09 1997-12-16 Warner-Lambert Company Breath-freshening edible compositions comprising menthol and an N-substituted-P-menthane carboxamide and methods for preparing same
US5626831A (en) * 1995-12-20 1997-05-06 Van Moerkerken; Arthur Method for relief and prevention of common cold, and compositions
US6469009B1 (en) 1996-04-08 2002-10-22 Ucb, S.A. Pharmaceutical compositions for the treatment of rhinitis
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
ATE444760T1 (de) * 1997-01-13 2009-10-15 Univ Emory Glutathion zur behandlung von influenzainfektionen
GB9707977D0 (en) * 1997-04-21 1997-06-11 Procter & Gamble Centre filled confectionery
GB9707978D0 (en) * 1997-04-21 1997-06-11 Procter & Gamble Throat soothing compositions
DE19814256A1 (de) * 1998-03-31 1999-10-07 Asta Medica Ag Feste, schnellzerfallende Cetirizin-Formulierungen
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IL160539A0 (en) * 2001-09-04 2004-07-25 Boehringer Ingelheim Int Anti-influenzal agents
WO2003084511A1 (en) 2002-04-04 2003-10-16 Pfizer Products Inc. Palatable chewable tablet
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
US20090203776A1 (en) * 2004-09-23 2009-08-13 Matias Jonathan R Methods of using menthol propyleneglycol-carbonate and analogs thereof for producing anti-inflammatory and anti-angiogenic effects
AU2016219620B2 (en) * 2006-04-21 2017-05-11 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
US20070249727A1 (en) 2006-04-21 2007-10-25 The Proctor & Gamble Company Compositions and kits useful for treatment of respiratory illness
US10022339B2 (en) 2006-04-21 2018-07-17 The Procter & Gamble Company Compositions and methods useful for treatment of respiratory illness
NZ614996A (en) * 2011-02-02 2014-12-24 Max Reynolds Composition of monoterpenoids having bactericidal properties
CA3042642A1 (en) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Extruded immediate release abuse deterrent pill
WO2015095391A1 (en) 2013-12-17 2015-06-25 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (en) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Immediate release abuse deterrent liquid fill dosage form
EP3209282A4 (en) 2014-10-20 2018-05-23 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
MX2020012233A (es) 2018-05-16 2021-01-29 Bayer Healthcare Llc Formula de suspension de alta concentracion para medicamentos en capsula de gel blanda para resfriado y gripe.
CN112972439A (zh) * 2019-12-16 2021-06-18 南京亿华药业有限公司 一种愈美泡腾片及其制备方法
AU2021217209A1 (en) 2020-02-03 2022-09-29 Johnson & Johnson Consumer Inc. A single layer chewable tablet comprising cetirizine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459425A (en) * 1981-11-20 1984-07-10 Takasago Perfumery Co., Ltd. 3-Levo-Menthoxypropane-1,2-diol

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1353381A (en) * 1971-02-04 1974-05-15 Wilkinson Sword Ltd Substituted p-menthanes and compositions containing them
KR100238565B1 (ko) * 1991-04-04 2000-02-01 데이비드 엠 모이어 상부 위장관 통증을 치료하기 위한 섭취가능한 약학적 조성물

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4459425A (en) * 1981-11-20 1984-07-10 Takasago Perfumery Co., Ltd. 3-Levo-Menthoxypropane-1,2-diol

Also Published As

Publication number Publication date
WO1994008551A3 (en) 1994-06-23
AU4930793A (en) 1994-05-09
JPH08502288A (ja) 1996-03-12
NZ256346A (en) 1997-04-24
EP0662840A1 (en) 1995-07-19
WO1994008551A2 (en) 1994-04-28
MX9306295A (es) 1994-04-29
CA2146637C (en) 2001-02-13

Similar Documents

Publication Publication Date Title
AU678561B2 (en) Pharmaceutical compositions and methods for treating cold symptoms
EP0316434B2 (en) Cough/cold mixtures comprising non-sedating antihistamine drugs
AU7604094A (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive
EP0695175A1 (en) Coated pharmaceutical compositions
US5648358A (en) Compositions and methods for treating respiratory disorders
WO1999015173A1 (en) Compositions and methods for treating respiratory disorders
CA2170485C (en) Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agents and caffeine
US4892877A (en) Antitussive liquid compositions containing phenol
CA2151912A1 (en) Use of s(+) antipodes of analgesic agents for the manufacture of a composition to treat respiratory disorders
WO1997004808A1 (en) Compositions containing analgesics and antihistamines and methods for treating respiratory disorders
AU663857B2 (en) Dextromethorphan antitussive compositions
AU672279B2 (en) Compositions containing caffeine and S(+)-ibuprofen or S(+)-flurbiprofen or S(+)-ketoprofen
IE913184A1 (en) Method for treating respiratory disorders
CA2090234C (en) Method for providing improved analgesic effect
JP2014159377A (ja) 昇華性薬物の昇華抑制方法
JP2003261442A (ja) 塩酸プソイドエフェドリンを含む軟カプセル剤